The rise of GLP-1 receptor agonists, such as Ozempic, Saxenda, Wegovy, and Mounjaro, has transformed how individuals manage Type 2 diabetes and obesity. These medications have enabled many to achieve significant weight loss, improving overall health and quality of life. However, rapid fat reduction, especially in the face, can lead to an aged, gaunt appearance, with sagging skin and hollow cheeks. This cosmetic concern—often referred to in conversations as the “Ozempic face effect”—has led patients to seek solutions that restore a youthful look while maintaining the benefits of their weight loss journey.